» Authors » Jordi Jimenez-Conde

Jordi Jimenez-Conde

Explore the profile of Jordi Jimenez-Conde including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 130
Citations 3798
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Macias-Gomez A, Jimenez-Balado J, Fernandez-Perez I, Suarez-Perez A, Vallverdu-Prats M, Guimaraens L, et al.
J Neurol Neurosurg Psychiatry . 2024 Feb; 95(7):675-681. PMID: 38302433
Background: We aimed to investigate the association between DNA-methylation biological age (B-age) calculated as age acceleration (ageAcc) and key aneurysmal subarachnoid haemorrhage (aSAH) complications such as vasospasm, delayed cerebral ischaemia...
12.
Gallego-Fabrega C, Temprano-Sagrera G, Carcel-Marquez J, Muino E, Cullell N, Lledos M, et al.
J Thromb Haemost . 2023 Dec; 22(4):936-950. PMID: 38103737
Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an increased risk of intracerebral...
13.
Peng H, Palma-Gudiel H, Soriano-Tarraga C, Jimenez-Conde J, Zhang M, Zhang Y, et al.
Clin Epigenetics . 2023 Jun; 15(1):106. PMID: 37370144
Background: DNA methylation has previously been associated with ischemic stroke, but the specific genes and their functional roles in ischemic stroke remain to be determined. Here we aimed to identify...
14.
Fernandez-Perez I, Jimenez-Balado J, Lazcano U, Giralt-Steinhauer E, Rey Alvarez L, Cuadrado-Godia E, et al.
Int J Mol Sci . 2023 Feb; 24(3). PMID: 36769083
Age acceleration (Age-A) is a useful tool that is able to predict a broad range of health outcomes. It is necessary to determine DNA methylation levels to estimate it, and...
15.
Macias-Gomez A, Suarez-Perez A, Rodriguez-Campello A, Giralt-Steinhauer E, Moreira A, Guisado-Alonso D, et al.
Neurol Sci . 2023 Feb; 44(6):2113-2120. PMID: 36749530
Introduction: Migraine with aura (MA) is a frequent stroke simulator that can lead to erroneous diagnosis and subsequent unnecessary acute or secondary prevention treatments. We analyzed clinical and laboratory data...
16.
Jimenez-Balado J, Giralt-Steinhauer E, Fernandez-Perez I, Rey L, Cuadrado-Godia E, Ois A, et al.
Biology (Basel) . 2023 Jan; 12(1). PMID: 36671726
In this manuscript we studied the relationship between WMH and biological age (B-age) in patients with acute stroke. We included in this study 247 patients with acute stroke recruited at...
17.
Bretzner M, Bonkhoff A, Schirmer M, Hong S, Dalca A, Donahue K, et al.
Neurology . 2022 Nov; 100(8):e822-e833. PMID: 36443016
Background And Objectives: While chronological age is one of the most influential determinants of poststroke outcomes, little is known of the impact of neuroimaging-derived biological "brain age." We hypothesized that...
18.
Bonkhoff A, Schirmer M, Bretzner M, Hong S, Regenhardt R, Donahue K, et al.
Hum Brain Mapp . 2022 Nov; 44(4):1579-1592. PMID: 36440953
This study aimed to investigate the influence of stroke lesions in predefined highly interconnected (rich-club) brain regions on functional outcome post-stroke, determine their spatial specificity and explore the effects of...
19.
Jaworek T, Xu H, Gaynor B, Cole J, Rannikmae K, Stanne T, et al.
Neurology . 2022 Oct; 99(16):e1738-e1754. PMID: 36240095
Background And Objectives: Current genome-wide association studies of ischemic stroke have focused primarily on late-onset disease. As a complement to these studies, we sought to identify the contribution of common...
20.
Cullell N, Soriano-Tarraga C, Gallego-Fabrega C, Carcel-Marquez J, Muino E, Llucia-Carol L, et al.
Clin Epigenetics . 2022 Sep; 14(1):124. PMID: 36180927
Background And Purpose: The neurological course after stroke is highly variable and is determined by demographic, clinical and genetic factors. However, other heritable factors such as epigenetic DNA methylation could...